| CKLF1 | Chemokine-like factor 1 |
| CCR4 | C-C chemokine receptor type 4 |
| TTC | 2,3,5-triphenyltetrazolium-chloride |
| MRI | Magnetic resonance imaging |
| ELISA | Enzyme-linked immunosorbent assay |
| qPCR | Quantitative real-time PCR |
| tPA | Tissue plasminogen activator |
| FDA | Food and Drug Administration |
| MI | Myocardial infarction |
| PE | Pulmonary embolism |
| tMCAO | Transient middle cerebral artery occlusion |
| pMCAO | Permanent middle cerebral artery occlusion |
| ICA | Internal carotid artery |
| ECA | External carotid artery |
| CCA | Common carotid artery |
| PBS | Phosphate-buffered saline |
| DWI | Diffusion weighted imaging |
| IL-1β | Interleukin 1β |
| TNF-α | Tumor necrosis factor α |
| LDH | Lactate dehydrogenase |
| BCA | Bicinchoninic acid |
| HE | Hematoxylin-eosin |
| LVSP | Left ventricular systolic pressure |
| LVDP | Left ventricular developed pressure |
| +dp/dtmax | The maximal ventricular pressure rise ratio during systolic period |
| −dp/dtmax | The maximal ventricular pressure decrease ratio during diastolic period |
| VE | Minute ventilation |
| FEV1 | Forced expiratory volume in the first second |
| BSA | Bovine serum albumin |
| DBA | 3,3-diaminobenzidin |
| PVDF | Polyvinylidene difluoride |
| ECL | Enhanced chemiluminescence |
| SD | Standard deviation. |